Patients are searching for this trial right now

This page is already ranking on Google. Activate it to start receiving pre-qualified patient leads directly in your inbox.

14-day free trial · $44/mo after · Cancel anytime · Money-back guarantee

NCT07778823 · Johns Hopkins University

Augmented Reality-Cardiopulmonary Resuscitation Support for Pediatric Resuscitation

(AR-CPR)

What this study is about

This study evaluates whether an augmented reality cardiopulmonary resuscitation feedback system (AR-CPR) can support health care providers in delivering high-quality chest compressions during pediatric cardiac arrest. AR-CPR provides real-time visual feedback on chest compression rate, depth, and recoil through a head-mounted augmented reality display.

View original scientific description

This study evaluates whether an augmented reality cardiopulmonary resuscitation feedback system (AR-CPR) can support health care providers in delivering high-quality chest compressions during pediatric cardiac arrest. AR-CPR provides real-time visual feedback on chest compression rate, depth, and recoil through a head-mounted augmented reality display. In this randomized, multicenter, international, simulation-based non-inferiority study, health care providers perform chest compressions during an 18-minute simulated pediatric cardiac arrest. Participants are assigned to receive either real-time feedback from AR-CPR or coaching from a trained human CPR coach. The primary objective is to determine whether the percentage of chest compressions meeting guideline targets for both rate and depth with AR-CPR is non-inferior to that achieved with human CPR coaching.

Interventions

DEVICE

AR-CPR

AR-CPR is a real-time augmented reality CPR feedback system designed to guide chest compression performance during pediatric cardiac arrest. The system uses a compression sensor containing an inertial measurement unit (IMU) and force-sensitive resistor (FSR) connected to a microcontroller. Sensor data are relayed to a Raspberry Pi 5 microcomputer running custom AR-CPR Coach software, which calculates chest compression rate, depth, and recoil. These metrics are transmitted wirelessly to a Vuzix M400 head-mounted display. The augmented reality interface provides numerical values and visual cues within the user's field of view. When performance is outside established targets, the system provides qualitative feedback and, for persistent deviations, escalates to explicit goal-directed instructions.

Primary outcome measures

Percentage of Overall Excellent CPR

Time frame: Up to 18 minutes

Percentage of chest compressions meeting the study-defined composite criterion for overall excellent CPR. This is a single composite outcome measure in which each chest compression is classified as meeting the outcome only when both compression rate and compression depth simultaneously meet American Heart Association Pediatric Advanced Life Support (AHA PALS) guideline targets. A compression must have both a rate of 100-120 compressions per minute and a depth of 5-6 cm to meet the composite outcome. If either the rate or depth is outside its target range, the compression does not meet the outcome. Rate and depth are therefore not evaluated as separate measurements for this primary outcome; they are simultaneous criteria used to determine whether each compression meets the single composite measure.

Who can participate

This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.

Inclusion criteria

  • Actively credentialed pediatric emergency department or pediatric intensive care unit nurse or clinical technician at a participating study site
  • Current American Heart Association (AHA) Pediatric Advanced Life Support (PALS) certification

Exclusion criteria

  • Inability to physically perform chest compressions
  • Need for prescription corrective lenses without having those corrective lenses available at the time of study participation

Where

  • St. Petersburg, Florida
  • Baltimore, Maryland
  • New York, New York
  • Philadelphia, Pennsylvania
  • Providence, Rhode Island
  • Dallas, Texas
  • Houston, Texas

Collaborators

The Hospital for Sick Children, Columbia University, Brown University, Children's Hospital of Philadelphia, Johns Hopkins All Children's Hospital, Children's Medical Center Dallas, Baylor College of Medicine, Agency for Healthcare Research and Quality (AHRQ)

Related conditions & keywords

Cardiac Arrest (CA)Pediatric Cardiac Arrest (Simulated)Cardiopulmonary Resuscitation (CPR)augmented realitycardiopulmonary resuscitationpediatric cardiac arrestcpr qualitychest compressionscpr coachingreal-time feedbackpediatric advanced life supportsimulation

Frequently asked questions

What is a clinical trial?

A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.

Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.

Will I be compensated?

Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.

Will I receive a placebo instead of treatment?

When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.

Can I leave a trial if I change my mind?

Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.

How long does a clinical trial last?

Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.

Data: ClinicalTrials.gov · synced Aug 21, 2026 · Source of record for eligibility and locations

📊
1 of 252 participants interested
0% interest

See if this study fits

A short prescreen based on this study's listed criteria. A coordinator confirms eligibility — this is not a medical assessment.

Preparing your pre-screening questions…

Study locations

Choose your preferred location, or select flexible during enrollment.

RECRUITING

St. Petersburg

Florida

Location available
RECRUITING

Baltimore

Maryland

Location available
RECRUITING

New York

New York

Location available
RECRUITING

Philadelphia

Pennsylvania

Location available
RECRUITING

Providence

Rhode Island

Location available
RECRUITING

Dallas

Texas

Location available
RECRUITING

Houston

Texas

Location available

Express your interest

Share your contact details and a study coordinator can follow up about screening.

Secure & Confidential

Your information is protected and will only be shared with the research team.

What participation can include

  • Study-related care provided by the research team
  • Close monitoring by medical professionals
  • Possible compensation for time and travel*
  • The option to withdraw at any time
  • Contributing to medical research that may help future patients

*Compensation varies by study. Confirm details with coordinator.

Typical next steps

  1. 1.Submit this form
  2. 2.Phone screening
  3. 3.In-person assessment if eligible
  4. 4.Begin participation

Looking for Cardiac Arrest (CA) Treatment in St. Petersburg?

Join others in Florida exploring innovative treatment options through clinical research

Cardiac Arrest (CA) Treatment Options in St. Petersburg, Florida

If you're searching for Cardiac Arrest (CA) treatment in St. Petersburg, participating in a clinical research study may provide access to innovative approaches under expert medical supervision. This study is actively recruiting participants in St. Petersburg, Baltimore, New York and surrounding areas.

Clinical trials offer participants the opportunity to receive cutting-edge treatments while contributing to medical research that may help future patients with Cardiac Arrest (CA). All study-related care is provided at no cost to participants.

Local Sites
3 locations in Florida
Now Enrolling
Up to 252 participants
Quick Start
Screening available now

Why Consider a Clinical Trial for Cardiac Arrest (CA)?

Potential Benefits

  • Access to new treatment approaches before public availability
  • Close monitoring by experienced medical professionals
  • Study-related care provided at no cost
  • Contribute to medical research for Cardiac Arrest (CA)

What to Expect

  • Initial screening to determine eligibility
  • Regular check-ups and monitoring visits
  • Possible compensation for time and travel
  • You can withdraw at any time

Frequently Asked Questions About This Cardiac Arrest (CA) Study

Important Clinical Trial Information

This information is provided for educational purposes and does not constitute medical advice. Clinical trial participation involves potential risks and benefits. Eligibility requirements apply and will be assessed during the screening process.

Study identifier: NCT07778823. For complete study details, visit ClinicalTrials.gov. Always consult with your healthcare provider before making decisions about your medical care or participating in clinical research.